Copyright Reports & Markets. All rights reserved.

Global Castration Resistant Prostate Cancer Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Castration Resistant Prostate Cancer Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Castration Resistant Prostate Cancer Treatment by Type
    • 1.3.1 Overview: Global Castration Resistant Prostate Cancer Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Castration Resistant Prostate Cancer Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Hormonal Therapy
    • 1.3.4 Adding An Anti-Androgen
    • 1.3.5 Stopping An Anti-Androgen
    • 1.3.6 Estrogens
    • 1.3.7 Chemotherapy
    • 1.3.8 Radiation Therapy
    • 1.3.9 Others
  • 1.4 Global Castration Resistant Prostate Cancer Treatment Market by Application
    • 1.4.1 Overview: Global Castration Resistant Prostate Cancer Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Ambulatory Surgical Centers
  • 1.5 Global Castration Resistant Prostate Cancer Treatment Market Size & Forecast
  • 1.6 Global Castration Resistant Prostate Cancer Treatment Market Size and Forecast by Region
    • 1.6.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America Castration Resistant Prostate Cancer Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Castration Resistant Prostate Cancer Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America Castration Resistant Prostate Cancer Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Active Biotech
    • 2.1.1 Active Biotech Details
    • 2.1.2 Active Biotech Major Business
    • 2.1.3 Active Biotech Castration Resistant Prostate Cancer Treatment Product and Solutions
    • 2.1.4 Active Biotech Castration Resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Active Biotech Recent Developments and Future Plans
  • 2.2 Diagnocure
    • 2.2.1 Diagnocure Details
    • 2.2.2 Diagnocure Major Business
    • 2.2.3 Diagnocure Castration Resistant Prostate Cancer Treatment Product and Solutions
    • 2.2.4 Diagnocure Castration Resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Diagnocure Recent Developments and Future Plans
  • 2.3 Glaxosmithkline
    • 2.3.1 Glaxosmithkline Details
    • 2.3.2 Glaxosmithkline Major Business
    • 2.3.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product and Solutions
    • 2.3.4 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Glaxosmithkline Recent Developments and Future Plans
  • 2.4 Northwest Biotherapeutics
    • 2.4.1 Northwest Biotherapeutics Details
    • 2.4.2 Northwest Biotherapeutics Major Business
    • 2.4.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product and Solutions
    • 2.4.4 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Northwest Biotherapeutics Recent Developments and Future Plans
  • 2.5 Millennium Pharmaceuticals
    • 2.5.1 Millennium Pharmaceuticals Details
    • 2.5.2 Millennium Pharmaceuticals Major Business
    • 2.5.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product and Solutions
    • 2.5.4 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Millennium Pharmaceuticals Recent Developments and Future Plans
  • 2.6 Hologic
    • 2.6.1 Hologic Details
    • 2.6.2 Hologic Major Business
    • 2.6.3 Hologic Castration Resistant Prostate Cancer Treatment Product and Solutions
    • 2.6.4 Hologic Castration Resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Hologic Recent Developments and Future Plans
  • 2.7 Spectrum Pharmaceuticals
    • 2.7.1 Spectrum Pharmaceuticals Details
    • 2.7.2 Spectrum Pharmaceuticals Major Business
    • 2.7.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product and Solutions
    • 2.7.4 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
  • 2.8 Abbott Laboratories
    • 2.8.1 Abbott Laboratories Details
    • 2.8.2 Abbott Laboratories Major Business
    • 2.8.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Product and Solutions
    • 2.8.4 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.9 Bayer Healthcare Pharmaceuticals
    • 2.9.1 Bayer Healthcare Pharmaceuticals Details
    • 2.9.2 Bayer Healthcare Pharmaceuticals Major Business
    • 2.9.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product and Solutions
    • 2.9.4 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bayer Healthcare Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Castration Resistant Prostate Cancer Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Castration Resistant Prostate Cancer Treatment by Company Revenue
    • 3.2.2 Top 3 Castration Resistant Prostate Cancer Treatment Players Market Share in 2023
    • 3.2.3 Top 6 Castration Resistant Prostate Cancer Treatment Players Market Share in 2023
  • 3.3 Castration Resistant Prostate Cancer Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Castration Resistant Prostate Cancer Treatment Market: Region Footprint
    • 3.3.2 Castration Resistant Prostate Cancer Treatment Market: Company Product Type Footprint
    • 3.3.3 Castration Resistant Prostate Cancer Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Castration Resistant Prostate Cancer Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Castration Resistant Prostate Cancer Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Castration Resistant Prostate Cancer Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Castration Resistant Prostate Cancer Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Castration Resistant Prostate Cancer Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America Castration Resistant Prostate Cancer Treatment Consumption Value by Application (2019-2030)
  • 6.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Country
    • 6.3.1 North America Castration Resistant Prostate Cancer Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Castration Resistant Prostate Cancer Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe Castration Resistant Prostate Cancer Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country
    • 7.3.1 Europe Castration Resistant Prostate Cancer Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Castration Resistant Prostate Cancer Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America Castration Resistant Prostate Cancer Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America Castration Resistant Prostate Cancer Treatment Market Size by Country
    • 9.3.1 South America Castration Resistant Prostate Cancer Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Castration Resistant Prostate Cancer Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Castration Resistant Prostate Cancer Treatment Market Drivers
  • 11.2 Castration Resistant Prostate Cancer Treatment Market Restraints
  • 11.3 Castration Resistant Prostate Cancer Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Castration Resistant Prostate Cancer Treatment Industry Chain
  • 12.2 Castration Resistant Prostate Cancer Treatment Upstream Analysis
  • 12.3 Castration Resistant Prostate Cancer Treatment Midstream Analysis
  • 12.4 Castration Resistant Prostate Cancer Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Castration Resistant Prostate Cancer Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose any symptom but in severe cases it can cause pain during urination and can cause problem during sexual intercourse. Castration resistant prostate cancer is referred to as a prostate cancer that is spread to other parts of body and is resistant to medical or surgical treatment. Risk factor for castration resistant prostate cancer includes genetic predisposition, geriatric population, unhygienic diet, medication exposure and many sexual partners. Diagnosis for the detection of castration resistant prostate cancer includes prostate imaging, biopsy, tumor marker and staging test. Crucial factor about castration resistant prostate cancer is that it is resistant to medical and surgical treatment. However, other treatment options that are available in the market include hormone therapy, immune modulation, antiangiogenic treatment and bone targeted therapies.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Castration Resistant Prostate Cancer Treatment industry chain, the market status of Hospital (Hormonal Therapy, Adding An Anti-Androgen), Ambulatory Surgical Centers (Hormonal Therapy, Adding An Anti-Androgen), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Castration Resistant Prostate Cancer Treatment.
    Regionally, the report analyzes the Castration Resistant Prostate Cancer Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Castration Resistant Prostate Cancer Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Castration Resistant Prostate Cancer Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Castration Resistant Prostate Cancer Treatment industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hormonal Therapy, Adding An Anti-Androgen).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Castration Resistant Prostate Cancer Treatment market.
    Regional Analysis: The report involves examining the Castration Resistant Prostate Cancer Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Castration Resistant Prostate Cancer Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Castration Resistant Prostate Cancer Treatment:
    Company Analysis: Report covers individual Castration Resistant Prostate Cancer Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Castration Resistant Prostate Cancer Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Ambulatory Surgical Centers).
    Technology Analysis: Report covers specific technologies relevant to Castration Resistant Prostate Cancer Treatment. It assesses the current state, advancements, and potential future developments in Castration Resistant Prostate Cancer Treatment areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Castration Resistant Prostate Cancer Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Castration Resistant Prostate Cancer Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Hormonal Therapy
    Adding An Anti-Androgen
    Stopping An Anti-Androgen
    Estrogens
    Chemotherapy
    Radiation Therapy
    Others
    Market segment by Application
    Hospital
    Ambulatory Surgical Centers
    Market segment by players, this report covers
    Active Biotech
    Diagnocure
    Glaxosmithkline
    Northwest Biotherapeutics
    Millennium Pharmaceuticals
    Hologic
    Spectrum Pharmaceuticals
    Abbott Laboratories
    Bayer Healthcare Pharmaceuticals
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Castration Resistant Prostate Cancer Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Castration Resistant Prostate Cancer Treatment, with revenue, gross margin and global market share of Castration Resistant Prostate Cancer Treatment from 2019 to 2024.
    Chapter 3, the Castration Resistant Prostate Cancer Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Castration Resistant Prostate Cancer Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Castration Resistant Prostate Cancer Treatment.
    Chapter 13, to describe Castration Resistant Prostate Cancer Treatment research findings and conclusion.

    Buy now